LIQUIDIA TECHNOLOGIES, INC.
🏢 View company profile →22Patents
22Active
22Granted
58Portfolio score
Filing activity: Dec 4, 2006 → Jul 12, 2023 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8944804B2 | Nanostructured surfaces for biomedical/biomaterial applications and processes thereof | Emerging Cross-Sectional Technologies | 33 | Active |
| US8128393B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 25 | Active |
| US7976759B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 11 | Active |
| US8444907B2 | Method for producing patterned materials | Emerging Cross-Sectional Technologies | 9 | Active |
| US8439666B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 8 | Active |
| US9314548B2 | Nanostructured surfaces for biomedical/biomaterial applications and processes thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8518316B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 6 | Active |
| US8662878B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 6 | Active |
| US10898494B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 5 | Active |
| US9340001B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 2 | Active |
| US8945441B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 2 | Active |
| US9205594B2 | Method for producing patterned materials | Emerging Cross-Sectional Technologies | 2 | Active |
| US9545737B2 | System and method for producing particles and patterned films | Emerging Cross-Sectional Technologies | 1 | Active |
| US8945527B2 | Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates | Emerging Cross-Sectional Technologies | 0 | Active |
| US11660304B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US11744836B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US12390475B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US11712442B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US9662809B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 0 | Active |
| US11744835B2 | Dry powder treprostinil for the treatment of pulmonary hypertension | Human Necessities | 0 | Active |
| US10717209B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | Emerging Cross-Sectional Technologies | 0 | Active |
| US9744715B2 | Method for producing patterned materials | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.